ASSESSING THE EFFICACY OF TADALAFIL IN REDUCING PULMONARY HYPERTENSION IN CHILDREN AND ADOLESCENTS AGED 5 MONTHS-15 YEARS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALIPOUR M.R.; LOOKZADE M.H.; MOTAHARI F.; NEMAYANDE M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Shahid Sadoughi University of Medical Sciences Year:2015 | Volume:23 | Issue:8 Page(s): 790-798

Download Full-Text

Persian Verion

View:

1,801

Download:

Cites:

Information Journal Paper

Title

ASSESSING THE EFFICACY OF TADALAFIL IN REDUCING PULMONARY HYPERTENSION IN CHILDREN AND ADOLESCENTS AGED 5 MONTHS-15 YEARS

Author(s)

ALIPOUR M.R. | LOOKZADE M.H. | MOTAHARI F. | NEMAYANDE M. | Issue Writer Certificate

Keywords

CHILDRENQ3

PULMONARY ARTERIAL HYPERTENSIONQ1

TADALAFILQ2

TREATMENTQ3

Abstract

Introduction: PULMONARY ARTERIAL HYPERTENSION in CHILDREN has consequences such as right ventricular failure and even death. Recently, the use of phosphodiesterase 5 inhibitors has been taken into account in the TREATMENT of pulmonary hypertension, among which TADALAFIL is more acceptable by parents and patients due to its single dose per day compared to sildenafil which should be taken 4 times a day. Therefore, this study aimed to investigate the effect of TADALAFIL on reducing pulmonary artery pressure in CHILDREN and adolescents aged 5 months to 15 years old.Methods: This before and after type study entailed 20 patients of 5-month to 15-year with PULMONARY ARTERIAL HYPERTENSION who had outpatient visits in Yazd Khatam-L-Anbiya clinic during 2013-2014. The participants were diagnosed by echocardiography, considering that they had not ever received any pulmonary arterial pressure lowering medicine up to now, whose congenital heart disease were inoperable. They were then treated using a single dose of oral TADALAFIL for 6 months. The collected data were analyzed using SPSS software via t-test and Chi-square tests.Results: Mean of pulmonary arterial pressure before and six months after taking TADALAFIL were 52.30±7.948 mmHg and 33.55±10.34 mmHg, respectively, which on average it was decreased by 18.75 mmHg (pv<0.0001). The mean of arterial oxygen saturation was reported %82.45±7.14 and %86.25±6.496 before and after taking TADALAFIL, respectively which was increased by 3.9% (pv<0.0001). The severity of tricuspid failure was reduced from moderate to mild level. No serious complication was observed leading to drug discontinuation in the patients’ follow-ups.Conclusion: The study findings revealed that TADALAFIL drug is effective on the TREATMENT of PULMONARY ARTERIAL HYPERTENSION within CHILDREN and adolescents. Moreover, it can be used instead of sildenafil, due to its single dose per day.

Cites

No record.

References

No record.

Cite

APA: Copy

ALIPOUR, M.R., LOOKZADE, M.H., MOTAHARI, F., & NEMAYANDE, M.. (2015). ASSESSING THE EFFICACY OF TADALAFIL IN REDUCING PULMONARY HYPERTENSION IN CHILDREN AND ADOLESCENTS AGED 5 MONTHS-15 YEARS. JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, 23(8), 790-798. SID. https://sid.ir/paper/36340/en

Vancouver: Copy

ALIPOUR M.R., LOOKZADE M.H., MOTAHARI F., NEMAYANDE M.. ASSESSING THE EFFICACY OF TADALAFIL IN REDUCING PULMONARY HYPERTENSION IN CHILDREN AND ADOLESCENTS AGED 5 MONTHS-15 YEARS. JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2015;23(8):790-798. Available from: https://sid.ir/paper/36340/en

IEEE: Copy

M.R. ALIPOUR, M.H. LOOKZADE, F. MOTAHARI, and M. NEMAYANDE, “ASSESSING THE EFFICACY OF TADALAFIL IN REDUCING PULMONARY HYPERTENSION IN CHILDREN AND ADOLESCENTS AGED 5 MONTHS-15 YEARS,” JOURNAL OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, vol. 23, no. 8, pp. 790–798, 2015, [Online]. Available: https://sid.ir/paper/36340/en

Related Journal Papers